Heart damage associated with cooked meat mutagens

Journal of Nutritional Biochemistry

Volumn 8, Issue 9, 1997, Pages 490-496

  Gaubatz, James W ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac myocytes; DNA damage; Food mutagens; Heart damage; Heterocyclic amines; Mitochondria

Indexed keywords

HETEROCYCLIC AMINE; MUTAGENIC AGENT;

COOKING; CYTOTOXICITY; DNA ADDUCT; HEART INJURY; HUMAN; MEAT; REVIEW;

EID: 0030879605     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(97)00080-6     Document Type: Review

References (76)

1. Gordon T., Kagan A., Garcia-Palmieri M., Kannel W.B., Zukel W.J., Tillotson T., Sorlie P., Hjortland M. Diet and its relation to coronary heart disease and death in three populations. Circulation. 63:1981;500-515.
2. Diet and Health Implications for Reducing Chronic Disease Risk. Report of the Committee on Diet and Health, Food, and Nutrition Board . 1989;National Academy Press, Washington, DC USA.
3. Felton J.S., Knize M.G. Heterocyclic amine mutagens/carcinogens in foods. Cooper C.S., Grover P.L. Chemical Carcinogenesis and Mutagenesis I, Handbook of Experimental Pharmacology. Vol 94:1990;471-502 Springer Verlag, Berlin.
4. Overvik E., Gustafsson J. Cooked-food mutagens current knowledge of formation and biological significance . Mutagenesis. 5:1990;437-446.
5. Ohgaki H., Takayama S., Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res. 259:1991;399-410.
6. Wakabayashi K., Nagaok M., Esumi H., Sugimura T. Food derived mutagens and carcinogens. Cancer Res. 52:1992;2092s-2098s.
7. Bjeldanes L.F., Morris M.M., Felton J.S., Healy S.K., Stuermer D.H., Berry P., Timourian H., Hatch F.T. Mutagens from the cooking of food III. Secondary sources of cooked dietary protein. Food Chem. Toxicol. 20:1982;365-369.
8. Kato R., Yamazoe Y. Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn. J. Cancer Res. 78:1987;297-311.
9. Sugimura T., Sato S., Wakabayashi K. Mutagens/carcinogens in pyrolysates of amino acids and proteins and cooked foods heterocyclic aromatic amines . Woo Y.T. Chemical Induction of Cancer, Structural Basis, and Biological Mechanisms. 1988;681-710 Academic Press, San Diego, CA USA.
10. Overvik E., Nilsson L., Fredholm L., Levin O., Nord C.E., Gustafsson J.A. Mutagenicity of gravy and pan residues from fried meat. Mutat. Res. 187:1987;47-55.
11. Felton J.S., Knize M.G. Mutagen formation in a model beef supernatant fraction IV. Hayatsu H. Mutagens in Food Detection and Prevention . 1991;58-66 CRC Press, Boca Raton, FL USA.
12. Ushiyama H., Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis. 12:1991;1417-1422.
13. Turesky R.J., Gross G.A., Stillwell W.G., Skipper P.L., Tannenbaum S.R. Species differences in metabolism of heterocyclic amines, human exposure, and biomonitoring. Environ. Health Perspect. 102:1994;47-51.
14. Yamazoe Y., Abu-Zeid M., Manabe S., Toyama S., Kato R. Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified P-450 enzymes. Carcinogenesis. 9:1988;105-109.
15. Wallin H., Mikalsen A., Guengerich F.P., Ingelman-Sundberg M., Solbery K.E., Rossland O.J., Alexander J. Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis. 11:1990;489-492.
16. Turesky J., Lang N.P., Butler C.H., Teitel C.H., Kadlubar F.F. Metabolic activation of carcinogenic heterocyclic aromatic amine by liver and colon. Carcinogenesis. 12:1991;1839-1845.
17. Snyderwine E.G., Schut H.A., Adamson R.H., Thorgeirsson U.P., Thorgeirsson S.S. Metabolic activation and genotoxicity of heterocyclic arylamines. Cancer Res. 52:1992;2099s-2103s.
18. Boobis A.R., Lynch A.M., Murray S., de la Torre R., Solans A., Farre M., Segura J., Gooderham N.J., Davies D.S. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximal carcinogens is their major route of metabolism in humans. Cancer Res. 54:1994;89-94.
19. Lin D-X, Lang N.P., Kadlubar F.F. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Drug Metab. Disposit. 23:1995;518-524.
20. Davis C.D., Schut H.A.J., Snyderwine E.G. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP. Carcinogenesis. 14:1993;2091-2096.
21. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx-, and PhIP-treated monkeys. Carcinogenesis. 14:1993;1389-1395.
22. Lin D., Kaderlik K.R., Turesky R.J., Miller D.W., Lay J.O. Jr, Kadlubar F.F. Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem. Res. Toxicol. 5:1992;691-697.
23. 2 atoms of guanine. Chem. Res. Toxicol. 7:1994;752-761.
24. Kaderlik K.R., Minchin R.F., Mulder G.J., Ilett K.F., Daugaard-Jensen M., Teitel C.H., Kadlubar F.F. Metabolic activation pathway for the formation of DNA adducts of the carcinogen, 2-amino-1-methyl-6-phenylimidazol[4,5-b]pyridine (PhIP), in rat extrahepatic tissues. Carcinogenesis. 15:1994;1703-1709.
25. Malfatti M.A., Buonarati M.H., Turteltaub K.W., Shen N.H., Felton J.S. The role of sulfation and/or acetylation in the metabolism of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Salmonella typhimurium and isolated rat hepatocytes. Chem. Res. Toxicol. 7:1994;139-147.
26. Turesky R.J., Bracco-Hammer I., Markovic J., Richli U., Kappeler A., Welti D.H. The contribution of N-oxidation to the metabolism of the food-borne carcinogen 1-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes. Chem. Res. Toxicol. 3:1990;524-535.
27. Snyderwine E.G., Buonarati M.H., Felton J.S., Turteltaub K.W. Metabolism of the food-derived mutagen/carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates. Carcinogenesis. 14:1993;2517-2533.
28. Meyer U.A. Polymorphism of human acetyltransferases. Environ. Health Perspect. 102:1994;213-215.
29. Lang N.P., Butler M.A., Jassengill J., Lawson M., Stotts C.R., Houer-Jensen M., Kadlubar F.F. Rapid metabolic phenotypes for acetyl transferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prevention. 3:1994;675-682.
30. Nagaok M., Sugimura T. Carcinogenic factors in food with relevance to colon cancer development. Mutat. Res. 290:1993;43-51.
31. 2OH-8-MeIQx) from beef extract. Carcinogenesis. 15:1994;21-26.
32. Nagao M., Ushijima T., Wakabayashi K., Ochiai M., Kushida H., Sugimura T. Dietary carcinogens and mammary carcinogenesis. Cancer. 74:1994;1063-1069.
33. Felton J.S. Heterocyclic amine-induced cancer and myocardial lesions in nonhuman primates. Environ. Health Perspect. 102:1994;138-139.
34. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods an analysis and implications for research . Carcinogenesis. 16:1995;39-52.
35. Takayama K., Yamashita K., Wakabayashi K., Sugimura T., Nagao M. DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Jpn. J. Cancer Res. 80:1988;1145-1148.
36. Snyderwine E.G., Schut H.A., Sugimura T., Nagao M., Adamson R.H. DNA adduct levels of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in tissues of cynomolgus monkeys after a single or multiple dosing. Carcinogenesis. 15:1994;2757-2761.
37. Adamson R.H., Snyderwine E.G., Thorgeirsson U.P., Schut H.A.J., Turesky R.J., Thorgeirsson S.S., Takayama S., Sugimura T. Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates. Ernster L. Xenobiotics and Cancer. 1991;289-301 Taylor and Francis Ltd, London UK.
38. Dragsted L.O., Frandsen H., Reistad R., Alexander J., Larsen J.C. DNA-binding and disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Carcinogenesis. 16:1995;2785-2793.
39. Takayama S., Sakamoto M., Hosada Y., Sugimura T. Calcification and angioproliferation in epicardium of mouse induced by mutagenic/carcinogenic heterocyclic amines. Proc. Jpn. Acad. Ser. B. 63:1987;161-163.
40. Davis C.D., Farb A., Thorgeirsson S.S., Virmani R., Snyderwine E.G. Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. Toxicol. Applied Pharm. 124:1994;201-211.
41. Overvik E., Ochiai M., Hirose M., Sugimura T., Nagao M. The formation of heart DNA adducts in F344 rats following dietary administration of heterocyclic amines. Mutat. Res. 256:1991;37-43.
42. Yamashita K., Adachi M., Kato S., Nakagama H., Ochiai M., Wakabayashi K., Sato S., Nagao M., Sugimura T. DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver dose-response on chronic administration . Jpn. J. Cancer Res. 81:1990;470-476.
43. Gaubatz J.W., Rooks S. Dietary-linked DNA damage in cardiac cells. FASEB J. 10:1995;A967.
44. Ames B.N. Mutagenesis and carcinogenesis endogenous and exogenous factors . Environ. Mutagenesis. 13:1989;1-12.
45. Li D., Randerath K. Modulation of DNA modification (I-compounds) levels in rat liver and kidney by dietary carbohydrate, protein, fat, vitamin, and mineral content. Mutat. Res. 275:1992;47-56.
46. Zak R. Cell proliferation during cardiac growth. Am. J. Cardiol. 31:1973;211-219.
47. Stockdale F.F., O'Neill M.C. Repair DNA synthesis in differentiated embryonic muscle cells. J. Cell Biol. 52:1972;589-597.
48. Hahn G.M., King D., Yang S.J. Quantitative changes in unscheduled DNA synthesis in rat muscle cells after differentiation. Nature New Biol. 230:1971;242-243.
49. Ho L., Hanawalt P.H. Gene-specific repair in terminally differentiating rat myoblasts. Mutat. Res. 255:1991;123-141.
50. Bohr V.A. Differential repair within the genome. Cancer Rev. 7:1987;28-55.
51. Bohr V.A. Gene specific DNA repair. Carcinogenesis. 12:1991;1983-1992.
52. Gaubatz J.W. DNA damage during aging of mouse myocardium. J. Mol. Cell. Cardiol. 18:1986;1317-1320.
53. Gaubatz J.W. Postlabeling analysis of indigenous aromatic DNA adducts in mouse myocardium during aging. Arch. Gerontol. Geriatr. 8:1989;47-54.
54. Gaubatz J.W. Genomic instability during aging of postmitotic mammalian cells. Macieria-Coelho A. Molecular Basis of Aging. 1995;71-136 CRC Press, Boca Raton, FL USA.
55. Bohr V.A., Okumoto D.S., Hanawalt P.C. Survival of UV-irradiated mammalian cells correlates with efficient DNA repair in an essential gene. Proc. Natl. Acad. Sci. USA. 83:1986;3830-3833.
56. Mellon I.M., Spivak G., Hanawalt P.C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell. 51:1987;241-249.
57. Gerdes, A.M., Schocken, D.D., Bishop, S.P., Smith, S.H., and Kozlovskis, P.L. (1995). Species-specific features of cardiac myocyte nuclei. J. Molec. Cell. Cardiol. 27, A37 1995.
58. Papoian T., Lewis W. Selective alterations in rat cardiac mRNA induced by doxorubicin Possible subcellular mechanisms . Exp. Mol. Pathol. 54:1991;112-121.
59. Bartowiak J., Kapuscinski J., Melamed M.R., Darzynkeiwicz S. Selective displacement of nuclear proteins by anti-tumor drugs having an affinity for nucleic acids. Proc. Natl. Acad. Sci. USA. 86:1989;5151-5154.
60. Fan L., Snyderwine E.G. Inhibition of plasmid reporter gene expression in CHO cells by DNA adducts of 2-Amino-1-methylimidazo[4,5-f]quinoline and 2-amino-1-methylimidazo[4,5-b]pyridine. Mol. Carcinogenesis. 10:1994;30-37.
61. Singh G., Sharkey S.M., Moorehead R. Mitochondrial DNA damage by anticancer agents. Pharm. Ther. 54:1992;217-230.
62. Wallace D.C. Mitochondrial genetics A paradigm for aging and degenerative diseases? Science. 256:1992;628-632.
63. Corral-Debrinski M., Shoffner J.M., Lott M.T., Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275:1992;169-180.
64. Cooper J.M., Mann V.M., Schapira A.H.V. Analysis of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle effect of ageing . J. Neurol. Sci. 113:1992;91-98.
65. Taylor R. Mitochondrial DNA may hold a key to human degenerative diseases. J. NIH Res. 4:1992;62-66.
66. Davis C.D., Schut H.A.J., Snyderwine E.G. Adduction of the heterocyclic amine food mutagens IQ and PhIP to mitochondrial and nuclear DNA in the liver of Fischer-344 rats. Carcinogenesis. 15:1994;641-645.
67. LeDoux S.P., Wilson G.L., Beecham E.J., Stevnsner T., Wassermann K., Bohr V.A. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis. 13:1992;1967-1973.
68. LeDoux S.P., Thangada M., Bohr V.A., Wilson G.L. Repair of alkali-labile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin. Cancer Res. 51:1991;775-779.
69. Driggers W.J., LeDoux S.P., Wilson G.L. Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J. Biol. Chem. 268:1993;22042-22045.
70. Zhao K., Murray S., Davies D.S., Boobis A.R., Gooderham N.J. Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human liver microsomes. Carcinogenesis. 15:1994;1285-1288.
71. Fan L., Schut H.A.J., Snyderwine E.G. Cytotoxicity, DNA adduct formation and DNA repair induced by 2-hydroxyamino-3-methylimidazo[4,5-f]quinoline and 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b][yridine in cultured human mammary epithelial cells. Carcinogenesis. 16:1995;775-779.
72. 32P-postlabeling . Chem. Res. Toxicol. 7:1994;733-739.
73. Turteltaub K.W., Felton J.S., Gledhill B.L., Vogel J.S., Southon J.R., Caffee M.W., Finkel R.C., Nelson D.E., Proctor I.D., Davis J.C. Accelerator mass spectrometry in biomedical dosimetry Relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA . Proc. Natl. Acad. Sci. USA. 87:1990;5288-5292.
74. Fengolio J.J., Silver M.D. Effects of drugs on the cardiovascular system. Silver M.D. Cardiovascular Pathology. 1992;1205-1229 Churchill Livingstone, New York.
75. Wakabayashi K. Animal studies suggesting involvement of mutagen/carcinogen exposure in atherosclerosis. Mutat. Res. 239:1990;181-187.
76. Thorogood M., Mann J., Appleby P., McPherson K. Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. Brit. Med. J. 308:1994;1667-1670.